[{"innerBlocks":[],"name":"core\/freeform","postId":111,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"Arcadia finished 2019 with an infusion of capital, closing a fully subscribed equity investment of $29.5 million, led by Cigna Ventures.The company indicated the funds would be used to fuel future growth. The Burlington, Mass.-based company made the announcement at the recent J.P. Morgan Healthcare Conference in San Francisco.Cigna Ventures executives highlighted Arcadia\u2019s potential to improve care delivery and better support healthcare organizations in the ongoing shift to value-based care.\u201cArcadia is accelerating the path to value-based care through its use of high-quality data, sophisticated analytics and workflow technology,\u201d says Tom Richards, global lead of strategy and business development at Cigna Ventures. Arcadia shares Cigna\u2019s vision for the future state of healthcare, and \u201cwith our investment and partnership, can bring even more resources and tools to healthcare professionals\u2014enhancing patient care and furthering the adoption of value-based care models,\u201d Richards adds.At the J.P. Morgan conference, Arcadia executives highlighted that the company achieved higher sales than it had planned.

\u201cWe are honored to partner with so many innovative organizations around the country as they transform healthcare delivery,\u201d said Sean Carroll, Arcadia's chief executive officer, The latest round of financing \u201cby Cigna Ventures and our existing slate of leading healthcare investors (reflects) our sustained growth in enabling economic success under challenging risk-based payment models.\u201dIn addition, Arcadia recently received the highest rating in the first-ever report on care management by KLAS Research, which gave high marks to its population health management software for its ability to identify and close care gaps.\u201cCare management is where the rubber meets the road in population health management,\u201d say authors of the KLAS study. \u201cMany provider organizations are able to access their data, analyze it, and ascertain patient risk, but now they are pushing for better, more automated ways to manage the care of at-risk patients.\u201dArcadia works with some of the largest and most advanced risk-bearing provider organizations in the country, Carroll adds. "Our focus has always been bringing together clinicians, data analysts, and administrators through a care management solution that acts as the glue in value-based performance programs, supporting high-quality care and improving the quality of life for patients."","saveContent":"Arcadia finished 2019 with an infusion of capital, closing a fully subscribed equity investment of $29.5 million, led by Cigna Ventures.The company indicated the funds would be used to fuel future growth. The Burlington, Mass.-based company made the announcement at the recent J.P. Morgan Healthcare Conference in San Francisco.Cigna Ventures executives highlighted Arcadia\u2019s potential to improve care delivery and better support healthcare organizations in the ongoing shift to value-based care.\u201cArcadia is accelerating the path to value-based care through its use of high-quality data, sophisticated analytics and workflow technology,\u201d says Tom Richards, global lead of strategy and business development at Cigna Ventures. Arcadia shares Cigna\u2019s vision for the future state of healthcare, and \u201cwith our investment and partnership, can bring even more resources and tools to healthcare professionals\u2014enhancing patient care and furthering the adoption of value-based care models,\u201d Richards adds.At the J.P. Morgan conference, Arcadia executives highlighted that the company achieved higher sales than it had planned.

Pop health vendor Arcadia raises $29.5M in latest investment round

More for you